Is Sarepta Therapeutics Inc. Stock a Short Sell?
Clinical stage biopharma Sarepta Therapeutics has attracted a large and growing short interest. Is the stock now a good short sell?
The Next Industry Google Plans to Transform
Google is leveraging its vast resources to create high-impact technologies that could transform modern medicine. Here is what you need to know.
Why Geron Corporation Stock Is Down a Shocking 52% in 2014
The FDA's clinical hold on imetelstat has rocked Geron's shares this year.